Search Results - "MAMIDI, R. N. V. S"
-
1
Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey
Published in Xenobiotica (01-07-2006)“…Levofloxacin's metabolism, excretion, and in vitro plasma protein binding, together with its pharmacokinetics, were studied in the Rhesus monkey in support of…”
Get full text
Journal Article -
2
Development and validation of a chiral liquid chromatographic method, based on Chiralpak ® to quantify enantiomers of (±)-DRF 2725 in rat plasma: lack of inversion of ragaglitazar ( S(−)-DRF 2725) to its antipode in plasma
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (25-09-2004)“…A selective, accurate and reproducible high-performance liquid chromatographic (HPLC) method for the separation of individual enantiomers of DRF 2725 […”
Get full text
Journal Article -
3
Pharmacokinetics, metabolism, excretion and plasma protein binding of 14 C-levofloxacin after a single oral administration in the Rhesus monkey
Published in Xenobiotica (01-07-2006)Get full text
Journal Article -
4
Novel Euglycemic and Hypolipidemic Agents. 1
Published in Journal of medicinal chemistry (07-05-1998)“…A series of [[(heterocyclyl)ethoxy]benzyl]-2,4-thiazolidinediones have been synthesized by the condensation of corresponding aldehyde 1 and…”
Get full text
Journal Article -
5
Polymorphism of dextromethorphan oxidation in South Indian subjects
Published in Clinical pharmacology and therapeutics (01-08-1999)“…One hundred fifty-six unrelated healthy South Indian subjects were phenotyped according to their ability to metabolize dextromethorphan to its O-demethylated…”
Get full text
Journal Article -
6
Characterization of clofazimine metabolites in humans by HPLC-electrospray mass spectrometry
Published in Arzneimittel-Forschung (01-03-1997)“…Clofazimine (CAS 2030-63-9) is an important drug used in the treatment of leprosy. Its important metabolites are investigated by thin layer chromatography…”
Get more information
Journal Article -
7
Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats
Published in Arzneimittel-Forschung (01-02-1999)“…The pharmacokinetics of the new insulin sensitizing agent, DRF-2189 ([5-[4-[2-(1-indolyl) ethoxy]phenyl]methyl]thiazolidine-2,4-dione, CAS 172647-53-9) were…”
Get full text
Conference Proceeding Journal Article